- ASSOCIATE PROFESSOR | Neurosurgery
- ASSOCIATE PROFESSOR | Otolaryngology
- Hospital Affiliations
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
- 3D Simulation
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Brain Tumor And Brain Cancer
- Brain, Spine Tumors
- Cerebrospinal Fluid Leak
- Chiari Malformation
- Endoscopic Pituitary Surgery
- Endoscopic Skull Base Surgery
- Hemifacial Spasm
- Pituitary Adenoma
- Pituitary Apoplexy
- Pituitary Diseases
- Sinus Cancer
- Skull Base Tumor/Cancer
- Skull Base Tumors
- Spinal Cord Tumors
- Spontaneous Cerebrospinal Fluid Leak
- Stereotactic Radiosurgery
- Trigeminal Neuralgia
- Ventriculoperitoneal Shunt
Brain, Brain Imaging, Clinical Genomics, Computer Simulation, Neural Networks, Neuroscience, Pituitary, Systems Neuroscience
BS, MS, Stanford University
MD, University of Pennsylvania
Internship, Surgery (General)
Mount Sinai Hospital
Mount Sinai Hospital
Fellowship, Skull Base Surgery
St. Luke's-Roosevelt Hospital Center
New York Magazine Best Doctors
Castle Connolly Top Doctors
Regional Top Doctor - Neurological Surgery
US News and World Report Selected Top Doctor-Neurosurgery
America's Top Surgeon Award
Consumer Research Council of America
Excellence in Neurosurgical Treatment
Compassionate Physician Award - National Award
Patient's Choice - Vital Health Care Group
Awarded to selected physicians by their patients for compassionate care in tumor treatment
Patient's Choice Award - National Award
Outstanding Patient Care in Neurosurgery
American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation
Outstanding Achievement in Neurosurgical Research - History
Ultra-High Field Tumor Mapping
Our Research Group is an NIH funded program developing newer techniques to accurately map tumors and anatomy using ultra-high field 7T MRI. This will allow for more precise and targeted surgical resections-ultimately for better patient outcome
Endoscopic Skull Base Surgery
Our group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. We are researching unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.
Tabaee A, Kamat A, Shrivastava R, Buchbinder D. Surgical management of pneumosinus dilatans frontalis in the setting of chronic rhinosinusitis and type III frontal Cell. The Journal of craniofacial surgery 2012 Jan; 23(1).
Shrivastava RK, Arginteanu MS, King WA, Post KD. Giant prolactinomas: clinical management and long-term follow up. Journal of neurosurgery 2002 Aug; 97(2).
Sen C, Triana AI, Berglind N, Godbold J, Shrivastava RK. Clival chordomas: clinical management, results, and complications in 71 patients. Journal of neurosurgery 2010 Nov; 113(5).
Shrivastava RK, Sen C, Costantino P. Surgical approaches to the craniocervical junction for the resection of chordomas. Clinical neurosurgery 2005; 52.
Shrivastava RK, Epstein FJ, Perin NI, Post KD, Jallo GI. Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis. Journal of neurosurgery. Spine 2005 Mar; 2(3).
Sen C, Shrivastava R, Anwar S, Triana A. Lateral transcondylar approach for tumors at the anterior aspect of the craniovertebral junction. Neurosurgery 2010 Mar; 66(3 Suppl).
Gologorsky Y, Shrivastava RK, Panov F, Mascitelli J, Signore AD, Govindaraj S, Smethurst M, Bronster DJ. Primary intraosseous cavernous hemangioma of the clivus: case report and review of the literature. Journal of neurological surgery reports 2013 Jun; 74(1).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Shrivastava did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.